Tumor of salivary gland
MONDO:0021357A neoplasm (disease) that involves the saliva-secreting gland.
Also known as: neoplasm of saliva-secreting gland, neoplasm of salivary gland, neoplasm of the salivary gland, saliva-secreting gland neoplasm, saliva-secreting gland neoplasm (disease), saliva-secreting gland tumor, saliva-secreting gland tumour, salivary gland neoplasm
1529 clinical trials for this condition and its sub-types, 9 tagged with Tumor of salivary gland itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Tumor of salivary gland
-
Salivary gland cancer 62 trials · 81 incl. sub-types
3 sub-types
- Salivary gland carcinoma 26 trials · 36 incl. sub-types Sub-types →
- Major salivary gland cancer 7 trials · 16 incl. sub-types Sub-types →
- Malignant tumor of minor salivary gland 0 trials Sub-types →
-
Neoplasm of major salivary gland 0 trials · 17 incl. sub-types
5 sub-types
- Major salivary gland cancer 7 trials · 16 incl. sub-types Sub-types →
- Parotid gland neoplasm 6 trials · 9 incl. sub-types Sub-types →
- Benign neoplasm of major salivary gland 0 trials · 3 incl. sub-types Sub-types →
- Sublingual gland neoplasm 0 trials Sub-types →
- Submandibular gland neoplasm 0 trials Sub-types →
-
Benign neoplasm of salivary gland 1 trial · 5 incl. sub-types
3 sub-types
- Benign neoplasm of major salivary gland 0 trials · 3 incl. sub-types Sub-types →
- Warthin tumor 1 trial
- Benign neoplasm of minor salivary gland 0 trials
-
Neoplasm of minor salivary gland 0 trials
2 sub-types
Most studied deeper sub-types
-
New targeted chemo aims to hit tumors harder, spare healthy tissue
Disease control Recruiting nowThis early-phase trial tests AVA6000, a chemotherapy drug that is designed to activate only in tumors, potentially reducing side effects. About 158 adults with advanced solid tumors (like breast, ovarian, or salivary gland cancer) will receive the drug intravenously. The main goa…
Phase 1 • Sponsor: Avacta Life Sciences Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a breast cancer drug combo treat rare tumors?
Disease control Recruiting nowThis trial tests two drugs, trastuzumab and pertuzumab, already approved for breast cancer, in people with rare cancers that have a specific genetic change called HER2 amplification or mutation. About 30 adults and children with various rare or hard-to-treat cancers will receive …
Phase 2/3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Hormone cocktail aims to stop rare salivary cancer recurrence
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of rezvilutamide (a hormone-blocking pill) and standard hormone therapy can prevent high-risk salivary duct cancer from returning after surgery and radiation. About 37 participants with androgen receptor-positive cancer will rec…
Phase 2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New MRI aims to spot cancer in salivary glands without a needle
Diagnosis Recruiting nowThis study is testing whether advanced MRI techniques can distinguish cancerous from non-cancerous salivary gland tumors. Thirty adults with a salivary gland lesion will receive one research MRI scan with contrast before their scheduled surgery. The goal is to improve diagnosis a…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 15:22 UTC
-
Simple test for throat cancer on the horizon?
Knowledge-focused Recruiting nowThis study from Mayo Clinic aims to find biological markers (biomarkers) in blood, tissue, and saliva that can signal the presence or absence of HPV-related oropharyngeal cancer. Researchers will follow 560 participants, including patients with and without the disease, to see if …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for immune clues in rare salivary gland cancers
Knowledge-focused Recruiting nowThis study is for 300 people with salivary gland tumors (both cancerous and non-cancerous) to learn how the immune system reacts to these rare cancers. Researchers will collect tumor tissue and blood samples before and after treatment to find immune markers that might predict how…
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC